RecruitingNot ApplicableNCT05521607

Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)

Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice in Newborns with High Melanin Content (Chicago)


Sponsor

Picterus AS

Enrollment

250 participants

Start Date

Jan 6, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.


Eligibility

Min Age: 1 DayMax Age: 14 Days

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Picterus Jaundice Pro (JP) for people with neonatal jaundice. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Day to 14 Days.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPicterus Jaundice Pro (JP)

Use Picterus Jaundice Pro, a smartphone app that is used to take photo of the newborns skin, where the Picterus calibration card is place.


Locations(1)

University of Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05521607


Related Trials